insights_auto
Bakit tumaas ang BOT 5.88%?
Tingnan ang Higit pang Detalyechevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.018
arrow_upward
+5.88%(+0.00100) 1D
Okt 6, 9:59:13 AM GMT+11 · AUD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BOT...
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
44.74M
Avg. na dami
5.79M
Dami
55.83K
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
44.74M
Avg. na dami
5.79M
Dami
55.83K
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
10 oras ang nakalipas
COMMENTARY: Wall Street bulls try on ‘S&P 10,000’ caps for size
MarketWatch
·
3 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Bloomberg.com
·
6 araw ang nakalipas
Stocks and Bonds Pause Ahead of US Data, Micron: Markets Wrap
The Motley Fool
·
4 araw ang nakalipas
Will the Stock Market Crash? History Gives a 95% Reason to Stay Calm
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Tungkol sa Botanix Pharmaceuticals Ltd